Quote:I agree with Mr Hammett that markets look pricey. Like him, I think a correction is likely, especially for the most expensive areas of the market, such as American shares.
However, given his concern, I would pick different funds. Fundsmith Equity, his second largest position, is invested heavily in American companies, which account for 73pc of the fund. An alternative is Schroder Global Recovery, which holds fewer expensive US companies and spreads its money more evenly between different markets.
This advice is so bad that it's bordering on being negligent.
The peak-to-trough drawdown in Fundsmith in Q1-2020 was 20%. The peak-to-trough drawdown in Schroder Global Recovery in Q1-2020 was 37%.
FS has a 5-year annualised return (admittedly a period over which its performance has somehwat slipped relative to its initial performance) of 18.5% vs the benchmark of 14.7%.
For Schroder Global Recovery, the 5 year performance is a measly 7.7% vs its benchmark of 14,1%.
As far as I can tell, the top holdings of Eni, ING, Centrica, StanChart, IMB are just toxic waste being passed off as "value" holdings.
I don't know what's more shocking - the performance of the fund or Fundhouse's view that re-allocating from FS into this fund is a shrewd investment move.